• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Insmed Incorporated (INSM)

    -NasdaqGS
    16.42 Up 0.37(2.31%) Dec 19, 4:00PM EST
    |After Hours : 16.42 0.00 (0.00%) Dec 19, 5:00PM EST
    Add to Portfolio
    Prev Close:16.05
    Open:16.15
    Bid:1.00 x 100
    Ask:N/A
    1y Target Est:30.17
    Beta:-0.23
    Next Earnings Date:N/A
    Day's Range:15.71 - 16.58
    52wk Range:11.25 - 22.29
    Volume:2,143,674
    Avg Vol (3m):599,503
    Market Cap:815.48M
    P/E (ttm):N/A
    EPS (ttm):-1.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INSMUp 2.31%815.48M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.07
    Quarterly EPS Est (Dec-14) :-0.55
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers a proven a... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback